Liposomes Co-Encapsulating Cisplatin/Mifepristone Improve the Effect on Cervical Cancer: In Vitro and In Vivo Assessment
Cervical cancer is usually diagnosed in the later stages despite many campaigns for early detection and continues to be a major public health problem. The standard treatment is cisplatin-based chemotherapy plus radiotherapy, but patient response is far from ideal. In the research for new drugs that...
Main Authors: | Fabricio Ledezma-Gallegos, Rafael Jurado, Roser Mir, Luis Alberto Medina, Laura Mondragon-Fuentes, Patricia Garcia-Lopez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/9/897 |
Similar Items
-
Pharmacokinetics and Anti-Tumor Efficacy of PEGylated Liposomes Co-Loaded with Cisplatin and Mifepristone
by: Karen Ocaña-Arakachi, et al.
Published: (2023-09-01) -
Preparation and cytotoxicity of cisplatin-containing liposomes
by: A.D. Carvalho Júnior, et al.
Published: (2007-08-01) -
Co-Encapsulation of Fisetin and Cisplatin into Liposomes for Glioma Therapy: From Formulation to Cell Evaluation
by: Morgane Renault-Mahieux, et al.
Published: (2021-06-01) -
Mifepristone inhibits non-small cell lung carcinoma cellular escape from DNA damaging cisplatin
by: Heather E. Kapperman, et al.
Published: (2018-11-01) -
Comparison of outpatient with inpatient mifepristone usage for cervical ripening: A randomised controlled trial
by: O. Baev, et al.
Published: (2023-06-01)